Remove Bioavailability Remove Clinical Development Remove Drug Delivery
article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology. Attendees will understand best practices for novel drug delivery design and development. What Is Dry Eye Disease?

article thumbnail

Skin Cancer Awareness Month 2024 and Insights from Medicus Pharma

XTalks

is a biotech and life sciences company dedicated to advancing the clinical development of innovative and groundbreaking therapeutic assets. Dr. Bokhari: Medicus Pharma, through its subsidiary SkinJect, addresses these needs with its innovative transdermal drug delivery system (TDDS).